Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

Links shared publicly online about this topic.

1,625
total visits

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.

View full resource at news-medical.net

Tags: Genetic, Disease and Condition, Pharma, Children's Health, Antibiotic, Sumycin, Doctor, Scientist